Curriculum vitae



Yüklə 481,01 Kb.
səhifə6/8
tarix22.10.2017
ölçüsü481,01 Kb.
#9283
1   2   3   4   5   6   7   8
Am. J. Transplant. (2002) 2 (Suppl.3):781




  1. Akalin E, Dikman S, Murphy D, Bromberg JS, Hancock WW. Differential expression of chemokines, chemokine receptors and ICOS in chronic allograft nephropathy (CAN) with or without transplant nephropathy (TGP). American Transplant Congress, Washington, DC., Am. J. Transplant. (2002) 2 (Suppl.3):950




  1. Ding Y, Qin L, Su R, Bromberg JS. IL-10 inhibits IFNand autoregulates IL-10 signaling through SOCSs. Experimental Biology 2002, New Orleans, LA., FASEB J. (2002) 16:A313.




  1. Honig SM, Mao X, Randolph G, Gunn M, Bromberg JS. FTY720 causes MRP, CCR7, and VLA-4 dependent lymph node homing. Experimental Biology 2002, New Orleans, LA., FASEB J (2002) 16:A1032.




  1. Chen D, Ding Y, Schröppel B, Chen D, Bromberg JS. Adenoviral vectors stimulate potent chemokine expression in transplanted hearts. American Society of Gene Therapy 2002, Boston, MA, Mol. Therapy (2002) 5:S7.




  1. Fu S, Mao X, Chen D, Ding Z, Bromberg JS. FIV virus mediated vIL-10 gene transfer prolongs cardiac allograft survival. American Society of Gene Therapy 2002, Boston, MA, Mol. Therapy (2002) 5:S234.




  1. Chen D, Ding Y, Fu S, Mao X, Bromberg JS. vIL-10 gene transfer inhibits expression of multiple proinflammatory genes in transplanted hearts. American Society of Gene Therapy 2002, Boston, MA, Mol. Therapy (2002) 5:S297.




  1. Zhang N, Schröppel B, Murphy B, Bromberg JS. Adenovirus transduction promotes the expression of multiple chemokines in -TC3 cells and murine pancreatic islets. American Society of Gene Therapy 2002, Boston, MA, Mol. Therapy (2002) 5:S346.




  1. Zhang N, Schröppel B, Murphy B, Bromberg JS, Sung R. Adenovirus transduction impairs engraftment of murine pancreatic islet transplants. American Society of Gene Therapy 2002, Boston, MA, Mol. Therapy (2002) 5:S350.




  1. Akalin E, Dikman S, Murphy B, Bromberg JS, Hancock W. Glomerular infiltration by CXCR3+ ICOS+ activated T cells in chronic allograft nephropathy (CAN) with transplant glomerulopathy (TGP). JASN (2002) 13:23A.




  1. Akalin E, Ames S, Sehgal V, Fotino M, Sung R, Daly L, Murphy B, Bromberg JS. Intravenous immunoglobulin (IVIG) and thymoglobulin induction treatment facilitate kidney transplantation in complement dependent cytotoxicity (CDC) B cell and flow cytometry (T and/or B cell) cross-match positive patients. JASN (2002) 13:48A.




  1. Sung RS, Zhang N, Schroppel B, Murphy B, Bromberg JS. Adenovirus transduction promotes the expression of CCL2 (MCP-1) in Beta-TC3 cells and murine pancreatic islets, and impairs engraftment of murine pancreatic islet transplants. Transplantation (2002) 74:A455.




  1. Safadi R, Ohta M, Alvarez CE, Cooreman MP, Eng FJ, Mehal W, Bromberg JS and Friedman SL. Diminished fibrosis and altered lymphocyte subsets in transgenic mice with hepatocyte overexpression of interleukin-10 . Hepatology (2002) 36(4): 330A.




  1. Fu S, Yopp AC, Mao X, Chen D, Zhang N, Ding Y, Bromberg JS. The subset of CD4+CD25+ T regulatory cells expressing high levels of L-selectin has the greatest suppressive and proliferative potential. Am. J. Transplant. (2003) 3 (suppl. 5):155.




  1. Yopp AC, Honig SM, Fu S, Bromberg JS. FTY720 enhances T cell homing to peripheral lymph nodes through sequential activation of multidrug transporters. Am. J. Transplant. (2003) 3 (suppl. 5):183.




  1. Yopp AC, Fu S, Honig SM, Krieger N, Bromberg JS. FTY720 enhances T cell migration to the CCR2 ligand MCP-1 (CCL2). Am. J. Transplant. (2003) 3 (suppl. 5):183.




  1. Akalin E, Ames S, Sehgal V, Fotino M, Daly L, Murphy B, Bromberg JS. Intravenous immunoglobulin (IVIG) and thymoglobulin induction treatment in complement dependent cytotoxicity (CDC) B cell and flow cytometry (T and/or B cell) cross-match positive patients. One year follow-up. Am. J. Transplant. (2003) 3 (suppl. 5):174.




  1. Paramesh A, Roayaie S, Doan Y, Bromberg JS, Akalin E. Post liver transplantation acute renal failure: factors predicting the development of end stage renal disease. Am. J. Transplant. (2003) 3 (suppl. 5):247.




  1. Chen D, Ding Y, Zhang N, Fu S, Schroppel B, Zhang H, Bromberg JS. Viral IL-10 gene transfer inhibits the expression of multiple chemokine and chemokine receptor genes induced by inflammatory or adaptive immune stimuli. Am. J. Transplant. (2003) 3 (suppl. 5):396.




  1. Chen D, Ding Y, Schroppel B, Zhang N, Fu S, Chen D, Zhang H, Bromberg JS. Ischemia-reperfusion, alloantigen, and adenovirus gene transfer result in differential expression of chemokine and chemokine receptor genes in cardiac grafts. Am. J. Transplant. (2003) 3 (suppl. 5):271.




  1. Ding Y, Su R, Bromberg JS. The mechanism of IL-10 and IL-6 mediated Th differentiation. Am. J. Transplant. (2003) 3 (suppl. 5):272.




  1. Zhang N, Schroppel B, Chen D, Murphy BM, Bromberg JS, Sung RS. Adenovirus vector transduction promotes the expression of multiple chemokines in murine pancreatic islets and impairs islet engraftment. Am. J. Transplant. (2003) 3 (suppl. 5):411.




  1. Zhang N, Schroppel B, Chen D, Murphy BM, Bromberg JS, Sung RS. Inhibition of islet engraftment by adenovirus vector: role of CCR2 and CCR5. Am. J. Transplant. (2003) 3 (suppl. 5):287.




  1. Schroppel B, Zhang N, Chen D, Hudkins KL, Kuziel WA, Sung R, Bromberg JS, Murphy B. The role of the MCP-1/CCR2 pathway in acute islet allograft rejection. Am. J. Transplant. (2003) 3 (suppl. 5):207.




  1. Liu J, Li Y, Boros P, Bromberg JS, Fishbein TM. A functional orthotopic small bowel transplant model in mice. Am. J. Transplant. (2003) 3 (suppl. 5):395.




  1. Krieger NR, Artis T, Roayaie S, Gondolesi GE, Florman S, Wayne M, Fishbein TM, Schiano T, Kim-Schluger L, Bromberg JS, Schwartz ME, Miller CM, Emre S. Safe use of hepatic allografts from older donors: evaluation of 179 cadaveric donors > 70 years. Am. J. Transplant. (2003) 3 (suppl. 5):450.




  1. Ku HT, Kubo A, Mao M, O’Connor R, Keller G, Bromberg J. Generation of endoderm vs. ectoderm derived insulin expressing cells from murine embryonic stem cells in culture. Am. J. Transplant. (2003) 3 (suppl. 5):172.




  1. Akalin E, Sehgal V, Ames S, Hossain S, Daly L, Murphy B, Bromberg JS. Cytomegalovirus disease in Thymoglobulin treated transplant recipients despite ganciclovir or valganciclovir prophylaxis. Am. J. Transplant. (2003) 3 (suppl. 5):505




  1. Yopp AC, Fu S, Honig SM, Bromberg JS. FTY720 enhances T cell migration to the CCR2 ligand, MCP-1. FASEB J. (2003) 17:C70.




  1. Ding Y, Bromberg JS. The mechanism of IL-10 and IL-6 mediated Th differentiation. FASEB J. (2003) 17:C131.




  1. Chen D, Ding Y, Zhang N, Fu S, Schroppel B, Bromberg JS. Viral IL-10 gene transfer regulates innate and adaptive immunity through chemokine and chemokine receptor gene expression in transplanted hearts. FASEB J. (2003) 17:C112.




  1. Chen D, Ding Y, Schroppel B, Zhang N, Fu S, Chen D, Zhang H, Bromberg JS. Differential chemokine and chemokine receptor gene induction by ischemia/ reperfusion, alloantigen, and gene transfer in cardiac grafts. FASEB J. (2003) 17:C133.




  1. Fu S, Yopp AC, Mao X, Chen D, Zhang N, Chen D, Mao M, Ding Y, Bromberg JS. The CD4+CD25+CD65L+ T regulatory cell subset has optimal suppressive and proliferative potential. FASEB J. (2003) 17:C311.




  1. Yopp AC, Fu S, Honig SM, Bromberg JS. FTY720 enhances T cell migration to the CCR2 ligand, MCP-1. Surgical Forum (2003).




  1. Akalin E, Fotino M, Friedlander R, Murphy B, Ames S, Sehgal V, Daly L, Bromberg JS. Intravenous immunoglobulin (IVIG) and Thymoglobulin induction treatment downregulates preformed donor-specific anti-HLA antibodies (DSA), but does not prevent the development of de novo DSA. ASN (2003).




  1. Akalin E, Bromberg JS, Sehgal V, Ames S, Daly L, Murphy B. Decreased incidence of cytomegalovirus infection in Thymoglobulin treated transplant patients with 6 months valganciclovir propylaxis. ASN (2003).




  1. Akalin E, Bromberg JS, Sehgal V, Ames S, Murphy B. Decreased incidence of cytomegalovirus infection in Thymoglobulin treated kidney transplant patients with 6-months valganciclovir prophylaxis. Am. J. Transplant. (2004) 4:148-149.




  1. Ochando JC, Llodra J, Randolph GJ, Rudensky AY, Bromberg JS, Krieger NR. Direct and indirect allorecognition: visualization of dendritic cell interactions in graft rejection. Am. J. Transplant.(2004) 4 (Suppl. 8):411.




  1. Zhang N, Fu S, Chen D, Zhang H, Ding Y, Bromberg JS. CD4+CD25+ T cells inhibit innate immune responses of murine islets. Am. J. Transplant.(2004) 4 (Suppl. 8):429.




  1. Yopp AC, Fu S, Ochando JC, Krieger NR, Bromberg JS. Inhibition of transendothelial T lymphocyte migration by P-FTY720 and sphingosine 1-phosphate (S1P). Am. J. Transplant.(2004) 4 (Suppl. 8):248.




  1. Akalin E, Bromberg JS, Sehgal V, Ames S, Daly L, Murphy B. 6 months valganciclovir prophylaxis significantly decreases cytomegalovirus infection incidence in Thymoglobulin treated transplant patients. Am. J. Transplant.(2004) 4 (Suppl. 8):495.




  1. Akalin E, Fotino M, Friedlander R, Murphy B, Ames S, Sehgal V, Daly L, Bromberg JS. Intravenous immune globulin (IVIG) and Thymoglobulin induction treatment down regulate preformed donor-specific anti-HLA antibodies (DSA), but do not prevent the development of de novo DSA. Am. J. Transplant.(2004) 4 (Suppl. 8):550.




  1. Ochando JC, Llodra J, Randolph GJ, Rudensky AY, Bromberg JS, Krieger NR. Dendritic cell interactions in rejection and tolerance. AAI 2004.




  1. Yopp AC, Fu S, Ochando JC, Krieger NR, Bromberg JS. Sphingosine 1-phosphate receptor (S1PR) activation: evidence for anatomically distinct chemokine compartments. AAI 2004.




  1. Ku HT, Zhang N, Kubo A, O’Connor R, Mao M, Keller G, Bromberg J. Committing murine embryonic stem cells to early endocrine pancreas in vitro. ADA 2004.




  1. Zhang N, Fu S, Chen D, Zhang H, Ding Y, Bromberg JS. CD4+CD25+ regulatory T cells protect islets from innate immune responses. ADA 2004.




  1. Zhang N, Clement N, Zhang H, Chen D, Fu S, Linden M, Bromberg JS. Transduction of pancreatic islets with pseudotyped adeno-associated virus: effect of viral capsid. Molec.Therapy, 2004 (Supplement 1) 9:S379.




  1. Zhang N, Fu S, Chen D, Ding Y, Bromberg JS. CD4+CD25+ regulatory T cells protect islets from innate immune response. Diabetes, 2004 (suppl. 2) 53:A26-A27(113-OR).




  1. Ku HT, Zhang N, Kubo A, O'Connor R, Mao M, Keller G, Bromberg JS. Committing murine embryonic stem cells to early endocrine pancreas in vitro. Diabetes, 2004 (suppl. 2) 53:A381(1591-P).




  1. Zhang N, Richter A, Harbaran S, Altomonte J, Zhang H,Song K, Meseck M, Bromberg JS, Dong H. Intra-graft production of VEGF is associated with enhanced islet neovascularization and improved outcome of marginal islet transplantation in diabetic mice. Diabetes, 2004 (suppl. 2) 53:A456(1908-P).




  1. Akalin E, Sehgal V, Ames S, Dikman S, Fotino M, Bromberg JS, Murphy B. Intravenous immunoglobulin treatment in a kidney transplant patient with chronic allograft nephropathy. Transplantation, 2005, 79:257-258




  1. Akalin E, Ames S, Sehgal V, Murphy B, Bromberg JS. Safety of using hepatitis B core antibody (HbcAb) or surface antigen (HbsAg) positive donors in kidney or pancreas transplantation. (ASN) 2004.




  1. Akalin E, Ames S, Sehgal V, Murphy B, Fotino M, Friedlander R, Bromberg JS. Intravenous immunoglobulin and thymoglobulin induction treatment in immunologically high-risk living kidney transplant recipients. ASN (2004).




  1. Schroppel B, Chen P, Bromberg JS, Murphy B. The role of donor-derived CCL2/MCP-1 in murine islet transplantation. ASN (2004).




  1. Akalin E, Ames A, Sehgal V, Murphy B, Fotino M, Friedlander R, Bromberg JS. Intravenous immunoglobulin and Thymoglobulin induction treatment in immunologically high-risk kidney transplant recipients. Transplantation, 2005, 79:742.




  1. Akalin E, Ames S, Sehgal V, Murphy B, Fotino M, Friedlander R, and Bromberg JS. Deleterious effect of preformed anti-HLA Class I donor-specific antibodies despite intravenous immunoglobulin induction treatment in living kidney transplant recipients. Am. J. Transplant. (2005) 5 (suppl. 11):324.




  1. Akalin E, Murphy B, Ames S, Sehgal V, Vanderbeek L and Bromberg JS. Rapid steroid withdrawal in hepatitis C virus positive kidney transplant recipients. Am. J. Transplant. (2005) 5 (suppl. 11):302.




  1. Akalin E, Ames S, Sehgal V, Murphy B and Bromberg JS. Safety of using Hepatitis B Core antibody or surface antigen positive donors in kidney or pancreas transplantation. Am. J. Transplant. (2005) 5 (suppl. 11):558-9.




  1. Zhang N, Chen D, Fu S, Ding Y, and Bromberg JS. Natural and TGF- Driven T regulatory cells (Treg) inhibit innate chemokine production by pancreatic islets and prevent early islet graft loss. Am. J. Transplant. (2005) 5 (suppl. 11):388.




  1. Zhang N, Chen D, Fu S, Ding Y, and Bromberg JS. CD4+CD25+T cells inhibit effector T cell migration. Am. J. Transplant. (2005) 5 (suppl. 11):256.




  1. Yopp AC, Ochando JC, Mao M, Ledgerwood L, Ding Y, and Bromberg JS. Sphingosine 1-phospate receptors regulate chemokine driven transendothelial migration of lymph node but not splenic T cells. Am. J. Transplant. (2005) 5 (suppl. 11):543.




  1. Chen D, Zhang N, Fu S, Ding Y, and Bromberg JS. CD4+CD25+ T regulatory cells inhibit islet chemokine expression through a cell contact dependent mechanism. Am. J. Transplant. (2005) 5 (suppl. 11):256.




  1. Hermesh T, Homma C, Ochando JC, Yopp AC, and Bromberg JS. CCL17+ alloantigen presenting cells migrate to the high endothelial venules during tolerization. Am. J. Transplant. (2005) 5 (suppl. 11):432.




  1. Ochando JC, Frimer M, Hermesh T, and Bromberg JS. Tolerogenic dendritic cells process alloantigen in a P and E-selection dependent manner. Am. J. Transplant. (2005) 5 (suppl. 11):248.




  1. Ochando JC, Yopp AC, Yang Y, Li Y, Boros P, Llodra J, Ding Y, Krieger NR and Bromberg JS. Peripheral development of alloantigen-specific Foxp3 regulatory T cells occurs in the lymph nodes of tolerized recipients. Am. J. Transplant. (2005) 5 (suppl. 11):416.




  1. Ochando JC, Yopp AC, Krieger NR, and Bromberg JS. Regulatory T cell lymph node migration is required to induce alloantigen-specific tolerance. Am. J. Transplant. (2005) 5 (suppl. 11):537.




  1. Ochando JC, Li Y, Boros P, Llodra J, Ding Y, and Bromberg JS. Alloantigen presenting plasmacytoid dendritic cells promote regulatory T cell development in the lymph node. Am. J. Transplant. (2005) 5 (suppl. 11):564-5.




  1. Yang Y, Ochando JC, Yopp A, Ding Y, and Bromberg JS. A new pathway for early IL-4 expression: C-MAF induction by IL-6. Am. J. Transplant. (2005) 5 (suppl. 11):436.




  1. Yang Y, Ochando JC, Yopp A, Ding Y, and Bromberg JS. Cyclosporin A and FK506 Block IL-6 Mediated C-MAF Expression. Am. J. Transplant. (2005) 5 (suppl. 11):222.




  1. Yang Y, Ochando JC, Yopp A, Ding Y and Bromberg JS. Stat 3 Trans-activates the C-MAF promoter in vivo. Am. J. Transplant. (2005) 5 (suppl. 11):226.




  1. Yang Y, Ochando JC, Ding Y, and Bromberg JS. CD8 Cell TC2 Development is limited by TCR initiated IL-4. Am. J. Transplant. (2005) 5 (suppl. 11):379.




  1. Ku TH, and Bromberg JS. Sox17 drives insulin I expression in differentiated murine embryonic Stem (ES) cells. Am. J. Transplant. (2005) 5 (suppl. 11):522.




  1. Blondeau B, Sauter B, Akalin E, Hoppenhauer L, Rodriguez-Laiz, Bromberg JS, Gondolesi G. Pre-transplant immunomodulation of highly sensitized small bowel transplant candidates with IVIG. Am. J. Transplant. (2005) 5 (suppl. 11):229.




  1. Yopp A, Ochando J, DingY, Bromberg JS. Sphingosine 1-phosphate receptors regulate chemokine driven migration of lymph node but not splenic T cells. J. Am. Coll. Surgeons (2005) 201(S3):S91-S92.




  1. Ku HT, Kim Y-J, Chai J, White P, Kaestner K, Bromberg JS. Insulin-expressing colonies developed from murine embryonic stem cell-derived pancreatic -cell progenitors. FASEB conference on Pancreatic Islets: From development to transplantation, Taos, NM, February 25, 2006.




  1. Akalin, EA, Ganeshan, SV, deBoccardo, G, Sehgal, V, Schroppel, B, Ames, S, Bromberg, JS, Murphy, B. Hyperuricemia is an independent risk factor for the development of cardiovascular disease in kidney transplant recipients. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Ochando, JC, Yang, Y, Ledgerwood, LG, Garin, A, Ding, Y, Lira, SA, Brombeg, JS. High endothelial venules upregulate adhesion molecules to promote lymph node homing during tolerance to vascularized allografts. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Zhang, N, Ochando, JC, Chen, D, Bromberg, JS. Migration to islet grafts but not lymph nodes is important for Treg effector function. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Zhang, N, Martin, AP, Lira, SA, Bromberg, JS. Protection of islet grafts from allo-and autoimmune destruction by blockade of the chemokine system. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Ochando, JC, Tacke, F, Randolph, GJ, Bromberg, JS. Monocyte-derived dendritic cells do not process alloantigen in donor vascularized allografts. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Ochando, JC, Homma, C, Tacke, F, Boros, P, Ding, Y, Nussenzweig, MC, Randolph, GJ, Bromberg, JS. Human and mouse plasmacytoid dendritic cells display phagocytic properties. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Ku, HT, Chai, J, Zhang, N, Qin, L, Bromberg, JS. Sox17 enhances differentiation of pancreatic-like structures from murine embryonic stem cells. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Ku, HT, Chai, J, Bromberg, JS. Generation of insulin and glucagon expressing cells from human embryonic stem cells in vitro. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Yang, Y, Ding, Y, Bromberg, JS. Identification of a novel T-BET enhancer conserved in human and murine CD8 T cells. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Yang, Y, Ochando, JC, Ding, Y, Bromberg, JS. C-MAF inhibits eomes expression and CD8 effector responses. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Akalin, E, Murphy, B, deBoccardo, G, Sehgal, V, Schroppel, B, Friedlander, R., Fotino, M, Ames, S, Bromberg, JS. Intravenous immunoglobulin and thymoglobulin induction treatment in kidney transplant recipients with donor-specific anti-HLA antibodies. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Ochando, JC, Yang, Y, Boros, P, Ding, Y, Jessberger, RJ, Bromberg, JS. SWAP-70 expression is required during tolerance to vascularized allografts. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Zhang, N, Ochando, JC, Chen, D, Bromberg, JS. TGF-β induces e-selectin ligand in Foxp3+ T regulatory cells. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Ledgerwood, LG, Ochando, JC, Yopp, AC, Bromberg, JS. Sphingosine 1-phosphate receptor activitiy is required for T cell migration from peripheral tissue into afferent lymph and lymph nodes. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Ochando, JC, Yang, Y, Garin, A, Ledgerwood, LG, Ding, Y, Jessberger, RJ, Trinchieri, G, Lira, SA, Randolph, GJ, Bromberg, JS. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Akalin, E, Murphy, B, Sehgal, V, Schroppel, B, deBoccardo, G, Bromberg, JS. Routine C4d staining of transplant kidney biopsies: low prevelance in chronic allograft nephropathy and transplant glomerulopathy patients. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Akalin, E, Murphy, B, Ames, S, Sehgal, V, deBoccardo, G, Schroppel, B, Bromberg, JS. Rapid steroid withdrawal in african-american kidney transplant recipients. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Akalin E, Ames, S, Friedlander, R, Sehgal, V, Murphy, B, Schroppel, B, deBoccardo, G, Fotino, M, Bromberg, JS. Intravenous immunoglobulin and thymoglobulin induction treatment in donor-specific anti-HLA antibody negative but cross-match positive kidney transplant recipients. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Ku, HT, Kim, Y, Chai, J, White, P, Kaestner, K, Bromberg, JS. Generation of insulin-expressing colonies from murine embryonic stem cell-derived β-cell progenitors. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Uva, P, deBoccardo, G, Bromberg, JS, Ames, S, Sehgal, V, Schroppel, B, Murphy, B, Akalin, E. Rapid steroid withdrawal in hepatitis C virus positive kidney transplant recipients. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Yang, Y, Ochando, JC, Ding, Y, Bromberg, JS. IL-12/Stat4 mediated T-BET expression is required for CD8 effector response againse adenovirus. World Transplant Congress, Boston, MA, July 22-27, 2006.




  1. Akalin, E, Murphy, B, Sehgal, V, Schroppel, B, deBoccardo, G, Bromberg, JS, Ames, S, Dikman, S. Low prevelance of C4D positivity in chronic allograft nephropathy and transplant glomerulopathy biopsies. American Society of Nephrology, San Diego, CA, November 14-19, 2006.




  1. Akalin, E, Ames, S, Murphy, B, Sehgal, V, deBoccardo, G, Schroppel, B, Friedlander, R, Fotino, M, Bromberg, JS. Intravenous immunoglobulin and thymoglobulin induction treatment in flow-cytometry cross-match positive kidney transplant recipients: 5 years experience. American Sociey of Nephrology, San Diego, CA, November 14-19, 2006.




  1. Bromberg, JS, LeRoith, D. Diabetes Cures – Is the Glass Half Full?
    Yüklə 481,01 Kb.

    Dostları ilə paylaş:
1   2   3   4   5   6   7   8



Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©muhaz.org 2024
rəhbərliyinə müraciət
gir | qeydiyyatdan keç
    Ana səhifə
Dərs
Dərslik
Guide
Kompozisiya
Mücərrəd
Mühazirə
Qaydalar
Referat
Report
Request
Review

yükləyin